Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

Ahn, 2007, Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity, Biochemistry, 46, 13019, 10.1021/bi701378g Ahn, 2008, Enzymatic pathways that regulate endocannabinoid signaling in the nervous system, Chem. Rev., 108, 1687, 10.1021/cr0782067 Alexander, 2005, Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes, Chem. Biol., 12, 1179, 10.1016/j.chembiol.2005.08.011 Blankman, 2007, A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol, Chem. Biol., 14, 1347, 10.1016/j.chembiol.2007.11.006 Boger, 1999, Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition, Bioorg. Med. Chem. Lett., 9, 265, 10.1016/S0960-894X(98)00734-3 Boger, 2000, Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide, Proc. Natl. Acad. Sci. USA, 97, 5044, 10.1073/pnas.97.10.5044 Bracey, 2002, Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling, Science, 298, 1793, 10.1126/science.1076535 Brandl, 2001, C-H…pi-interactions in proteins, J. Mol. Biol., 307, 357, 10.1006/jmbi.2000.4473 Chang, 2006, Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms, Br. J. Pharmacol., 148, 102, 10.1038/sj.bjp.0706699 Cravatt, 1996, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, 384, 83, 10.1038/384083a0 Cravatt, 2001, Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc. Natl. Acad. Sci. USA, 98, 9371, 10.1073/pnas.161191698 Cravatt, 2004, Functional disassociation of the central and peripheral fatty acid amide signaling systems, Proc. Natl. Acad. Sci. USA, 101, 10821, 10.1073/pnas.0401292101 Deutsch, 1997, Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase, Biochem. Pharmacol., 53, 255, 10.1016/S0006-2952(96)00830-1 Di Marzo, 2008, Endocannabinoids: synthesis and degradation, Rev. Physiol. Biochem. Pharmacol., 160, 1, 10.1007/112_0505 Di Marzo, 2007, Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology, Chem. Biol., 14, 741, 10.1016/j.chembiol.2007.05.014 Dixon, 1980, Efficient analysis of experimental observations, Annu. Rev. Pharmacol. Toxicol., 20, 441, 10.1146/annurev.pa.20.040180.002301 Fegley, 2005, Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation, J. Pharmacol. Exp. Ther., 313, 352, 10.1124/jpet.104.078980 Fowler, 2006, The cannabinoid system and its pharmacological manipulation–a review, with emphasis upon the uptake and hydrolysis of anandamide, Fundam. Clin. Pharmacol., 20, 549, 10.1111/j.1472-8206.2006.00442.x Glaser, 2005, Anandamide transport: a critical review, Life Sci., 77, 1584, 10.1016/j.lfs.2005.05.007 Gobbi, 2005, Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis, Proc. Natl. Acad. Sci. USA, 102, 18620, 10.1073/pnas.0509591102 Hillard, 2003, Cellular accumulation of anandamide: consensus and controversy, Br. J. Pharmacol., 140, 802, 10.1038/sj.bjp.0705468 Holt, 2005, Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors, Br. J. Pharmacol., 146, 467, 10.1038/sj.bjp.0706348 Jayamanne, 2006, Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models, Br. J. Pharmacol., 147, 281, 10.1038/sj.bjp.0706510 Kathuria, 2003, Modulation of anxiety through blockade of anandamide hydrolysis, Nat. Med., 9, 76, 10.1038/nm803 Keith, 2008, Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase, Bioorg. Med. Chem. Lett., 18, 4838, 10.1016/j.bmcl.2008.07.081 Koutek, 1994, Inhibitors of arachidonyl ethanolamide hydrolysis, J. Biol. Chem., 269, 22937, 10.1016/S0021-9258(17)31599-5 Lambert, 2002, The palmitoylethanolamide family: a new class of anti-inflammatory agents?, Curr. Med. Chem., 9, 663, 10.2174/0929867023370707 Leung, 2003, Discovering potent and selective inhibitors of enzymes in complex proteomes, Nat. Biotechnol., 21, 687, 10.1038/nbt826 Leung, 2006, Inactivation of N-acyl ethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids, Biochemistry, 45, 4720, 10.1021/bi060163l Lichtman, 2004, Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity, J. Pharmacol. Exp. Ther., 311, 441, 10.1124/jpet.104.069401 Lichtman, 2004, Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia, Pain, 109, 319, 10.1016/j.pain.2004.01.022 Liu, 1999, Activity-based protein profiling: the serine hydrolases, Proc. Natl. Acad. Sci. USA, 96, 14694, 10.1073/pnas.96.26.14694 Long, 2009, Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects, Nat. Chem. Biol., 5, 37, 10.1038/nchembio.129 Massa, 2004, The endogenous cannabinoid system protects against colonic inflammation, J. Clin. Invest., 113, 1202, 10.1172/JCI200419465 McFarland, 2004, Anandamide transport, Pharmacol. Ther., 104, 117, 10.1016/j.pharmthera.2004.07.008 McKinney, 2005, Structure and function of fatty acid amide hydrolase, Annu. Rev. Biochem., 74, 411, 10.1146/annurev.biochem.74.082803.133450 Mechoulam, 1986 Mileni, 2008, Structure-guided inhibitor design for human FAAH by interspecies active site conversion, Proc. Natl. Acad. Sci. USA, 105, 12820, 10.1073/pnas.0806121105 Moreira, 2008, Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors, Neuropharmacology, 54, 141, 10.1016/j.neuropharm.2007.07.005 Naidu, 2007, Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality, Psychopharmacology (Berl.), 192, 61, 10.1007/s00213-006-0689-4 Nomura, 2008, Activation of the endocannabinoid system by organophosphorus nerve agents, Nat. Chem. Biol., 4, 373, 10.1038/nchembio.86 Pacher, 2006, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol. Rev., 58, 389, 10.1124/pr.58.3.2 Patricelli, 1999, Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolase with distinct catalytic features, Biochemistry, 38, 9804, 10.1021/bi990637z Patricelli, 2001, Direct visualization of serine hydrolase activities in complex proteome using fluorescent active site-directed probes, Proteomics, 1, 1067, 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4 Russo, 2007, The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice, J. Pharmacol. Exp. Ther., 322, 236, 10.1124/jpet.107.119941 Saghatelian, 2004, Assignment of endogenous substrates to enzymes by global metabolite profiling, Biochemistry, 43, 14332, 10.1021/bi0480335 Speers, 2004, Profiling enzyme activities in vivo using click chemistry methods, Chem. Biol., 11, 535, 10.1016/j.chembiol.2004.03.012 Speers, 2003, Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition, J. Am. Chem. Soc., 125, 4686, 10.1021/ja034490h Swinney, 2004, Biochemical mechanisms of drug action: what does it take for success?, Nat. Rev. Drug Discov., 3, 801, 10.1038/nrd1500 Tsuboi, 2005, Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase, J. Biol. Chem., 280, 11082, 10.1074/jbc.M413473200 Wei, 2006, A second fatty acid amide hydrolase with variable distribution among placental mammals, J. Biol. Chem., 281, 36569, 10.1074/jbc.M606646200 Zhang, 2007, Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets, Neuropharmacology, 52, 1095, 10.1016/j.neuropharm.2006.11.009